<SEC-DOCUMENT>0001144204-11-034015.txt : 20110606
<SEC-HEADER>0001144204-11-034015.hdr.sgml : 20110606
<ACCEPTANCE-DATETIME>20110606060107
ACCESSION NUMBER:		0001144204-11-034015
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110606
FILED AS OF DATE:		20110606
DATE AS OF CHANGE:		20110606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XTL BIOPHARMACEUTICALS LTD
		CENTRAL INDEX KEY:			0001023549
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51310
		FILM NUMBER:		11893866

	BUSINESS ADDRESS:	
		STREET 1:		XTL BIOPHARMACEUTICALS LTD
		STREET 2:		C/O ALSTON & BIRD LLP, 90 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		972 9 955 7080

	MAIL ADDRESS:	
		STREET 1:		85 MEDINAT HAYEHUDIM ST.
		STREET 2:		PITUACH, PO BOX 4033
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			46140
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v225030_6k.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td align="left" valign="top" width="72%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#160;&#160;&#160;&#160;</font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, D.C. 20549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 6-K</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Report of Foreign Private Issuer</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to Rule 13a-16 or 15d-16</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of the Securities Exchange Act of 1934</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the month of June, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission File Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">000-51310</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">XTL Biopharmaceuticals Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation of registrant&#8217;s name into English)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">85 Medinat Hayehudim St., Herzliya</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pituach, PO Box 4033,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Herzliya 46140, Israel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address of principal executive offices)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 20-F&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">x</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form 40-F&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">x</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-<font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;N/A&#160;&#160;&#160;&#160; </font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td align="left" valign="top" width="72%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#160;&#160;&#160;&#160;</font></font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incorporation by Reference: This Form 6-K of XTL Biopharmaceuticals Ltd. dated June 6, 2011 is hereby incorporated by reference into the registration statements on Form F-3 (File No. 333-141529, File No. 333-147024 and File No. 333-153055) filed by XTL Biopharmaceuticals Ltd. with the Securities and Exchange Commission on March 23, 2007 , October 30, 2007 and August 15, 2008, respectively, and the registration statements on Form S-8 (File No. 333-148085, File No. 333-148754 and File No. 333-154795) filed by XTL Biopharmaceuticals Ltd. with the Securities and Exchange Commission on December 14, 2007, January 18, 2008, and October 28, 2008, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">XTL Biopharmaceuticals (the "Company") Convenes an Annual General Meeting</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attached hereto is an English translation (from Hebrew) of a notice for convening an Annual General Meeting, as submitted on the Tel Aviv Stock Exchange (TASE).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In order to vote, ADR holders should contact BNY Mellon Depositary Receipts at Tel (212) 815 8223.</font></div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 2 -</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo1.jpg"></font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">XTL Biopharmaceuticals Ltd.</font></font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the Company</font>")</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">June 1, 2011</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">To</font></div>
</td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">To</font></div>
</td>
</tr><tr>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Israel Securities Authority Ltd.</font></div>
</td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Tel-Aviv Securities Stock Exchange Ltd.</font></div>
</td>
</tr><tr>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Through the Magna System</font></font></div>
</td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="45%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Through the Magna System</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Sirs/Mmes.,</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Immediate report on Convening of an Annual General Meeting of the Company's shareholders</font></font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company is hereby pleased to present an immediate report on the convening of an annual general meeting of the Company's shareholders to be held on July 12, 2011, in accordance with the Israeli Companies Law, 1999 ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the Companies Law</font>"), all as follows:</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On July 12, 2011, at 10:00 am, a shareholders' meeting will be held at the offices of the Company's attorneys, Kantor &amp; Co., at 12 Abba Hillel Silver Road, Ramat-Gan, Israel, for the purpose of discussing and approving the following resolutions:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Receipt and discussion of the Company's directors' report and financial statements as of December 31, 2009 and 2010.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Reappointment of the Financial Auditors</font> - the proposed resolution is as follows: to approve the appointment of Kesselman &amp; Kesselman (A member of PricewaterhouseCoopers International Limited) as the Company's financial auditors for 2010 and 2011 and authorizing the Company's board of directors to determine their fee.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Reappointment of Directors</font> - the proposed resolution is as follows: to approve the reappointment of Messrs. Marc Allouche, Amit Yonay and David Grossman as directors in the Company until the next annual meeting. The voting on each of those directors will be done individually.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendment of the Company's Articles of Association</font> - it is proposed to amend the Company's Articles of Association such that they will introduce regulations regarding the indemnification and liability insurance of officers in the Company as specified in this section below. The introduction of these proposed regulations is designed to adapt the provisions of the Company's Articles of Association to certain liabilities prescribed by the Law for Improving Enforcement in the Israeli Securities Authority (Legislative Amendments), 2011.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 1 to the articles of association will introduce the definition of "administrative proceeding" as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"A proceeding according to chapters H3 (imposition of monetary sanction by the Israeli Securities Authority), H4 (imposition of administrative enforcement procedures by the administrative enforcement committee), or I1 (arrangement for avoiding preconditioned initiation or termination of proceedings) to the Israeli Securities Act, 1969, as amended from time to time".<a name="Page2"><!--EFPlaceholder--></a></font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 3 -</font></font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo2.jpg"></font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 37.1(d) to the articles of association will be added as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"Monetary liability imposed on the officer(s) for all the injured parties resulting from the violation of the administrative proceeding".</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 37.1(e) to the articles of association will be added as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"Expenses incurred by an officer in connection with an administrative proceeding held in the officer's case, including reasonable litigation expenses and including attorney's fees".</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 37.2(c) to the articles of association will be added as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"Monetary liability imposed on the officer(s) for all the injured parties resulting from the violation of the administrative proceeding".</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 37.2(d) to the articles of association will be added as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"Expenses incurred by an officer(s) in connection with an administrative proceeding held in the officer's case, including reasonable litigation expenses and including attorney's fees".</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">The proposed resolution</font>: "approving the proposed amendments to the Company's Articles of Association as detailed in paragraphs 1d(1) through 1d(5) above".</font></font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 37pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Amending the Letters of Indemnification previously granted by the Company to its officers (including directors), who are directors not on behalf of the controlling shareholder</font> - subject to the amendment of the Company's Articles of Association (as defined in section d above), amending the letters of indemnification granted to officers in the Company, including directors and officers who will serve in the Company from time to time ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the officers</font>") to also include a liability for an undertaking in advance to&#160;&#160;indemnify for monetary liability imposed on officers to pay the injured parties resulting from the violation of an administrative proceeding (as defined in paragraph d1 above), as well as expenses incurred by the officer in connection with an administrative proceeding held in its case(s), including reasonable litigation expenses and attorney's fees, based on the letter of indemnification.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">The proposed resolution</font>: "approving the amendment to the letters of indemnification that had been granted to currently serving officers (including directors) and that will be granted to officers serving in the Company from time to time.</font></font></div>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 4 -</font></font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo2.jpg"></font></font></div>

<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font>
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 37pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Insurance of Officers (recurring agreement)</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approving a "<font style="DISPLAY: inline; TEXT-DECORATION: underline">recurring agreement</font>" effective for a period of three years from September 1, 2011 through August 31, 2014 for the Company's engagement in the ordinary course of business in future insurance policies for covering the liability of directors and officers, as they will be from time to time, including directors and officers who are or might be considered to be controlling shareholders in the Company, all under a term sheet as defined in the exemptions to the regulations.</font></font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company will be entitled, during the aforesaid period, to purchase a liability D&amp;O policy covering up to US$&#160;10 million per event and per insurance year. The annual premium paid by the Company shall not exceed US$&#160;75 thousand plus an amount representing up to 10% of said amount (subject to premium updates that might be required due to offerings, if any, etc.). The Company will be entitled to purchase liability insurance that exceeds US$&#160;10 million provided that the annual premium paid by the Company shall not be above annual premium amount.</font></font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It should be noted that as long as the Company has valid insurance for its directors and officers, the policy will include all of the directors and/or officers that have left the Company by the end of seven years from the date of departure, subject to maintaining the policy terms will not be materially different (not more than 10% difference) from the existing policy terms on the date of departure. If the Company ceases in the future to enter into directors' and officers' liability insurance policies or if the terms of the renewed policy after the date of departure are materially inferior (more than 10% difference) to those in the previous policy prior to the date of departure, the Company will undertake to purchase run-off insurance for the directors and officers for the remaining period of up to seven years from the date of the director's and/or officer's departure and under terms that will not be materially different (not more than 10% difference) from the previous policy prior to the date of departure, at a cost that will not exceed double the ceiling of the cost of an annual premium for the insurance of directors and officers as above.</font></font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the annual general meeting, a legal quorum will constitute the presence of at least two (2) shareholders, by themselves or their representatives, holding together at least 33% of the total voting rights in the Company. If at the elapse of half an hour from the meeting's scheduled time the legal quorum is not found, the meeting will be postponed by one week for the same day, at the same time and venue as scheduled for the original meeting, or for a different date and/or venue as determined by the board of directors in a notice to the shareholders. The postponed meeting will discuss the same agenda as planned for the original meeting. If a legal quorum is not found in the postponed meeting at the elapse of half an hour from the meeting's scheduled time, the two shareholders that are present, by themselves or their representatives, will constitute a legal quorum and the meeting will be entitled to discuss the issues on the agenda.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The date for establishing the shareholders' entitlement to vote in the general meeting, as stated in Section 182(b) to the Companies Law, is Thursday, June 23, 2011 ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the record date</font>"). According to the Israeli Companies Regulations (Proof of Share Ownership for Voting in the General Meeting), 2000, a shareholder that has a share(s) registered in its name at a member of the Stock Exchange whereby that share(s) is included in the shares registered in the Company's Registrar, and is interested in voting in the general meeting, must produce to the Company the Tel Aviv Stock Exchange member's proof of the shareholder's ownership over the share(s) on the record date, as required by said regulations.</font></div>
</td>
</tr></table>
</div>

<div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 5 -</font></font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
</div>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo2.jpg"></font></font></div>

<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's shareholders are entitled to participate and vote in the meeting by themselves or through a legally certified agent. The document certifying the agent to vote ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the letter of appointment</font>") and a power of attorney by virtue of which the letter of appointment was signed (if any) will be deposited with the Company's attorneys at least 48 hours before the meeting begins.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Israeli Securities Authority's magna distribution site ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">magna</font>") and website address where the formats of proxy statements and position statements can be found as they are defined in Section 88 to the Israeli Companies Law are: <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.magna.isa.gov.il</font> and <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.tase.co.il</font>, respectively. Voting as per the proxy statement will be done on the second part of the proxy statement as published in the magna. A shareholder may contact the Company directly and receive the formats of the proxy statement and position statement(s) (if any). A Stock Exchange member will e-mail a link to the formats of the proxy statement and position statement(s) on the magna, at no charge, to any shareholder that is not registered at the shareholders' registrar and whose shares are registered at that Stock Exchange member, if the shareholder so requests, provided that the notice is given with respect to a specific securities account and prior to the record date. A shareholder whose shares are registered at a Stock Exchange member is entitled to receive the proof of ownership from the Tel Aviv Stock Exchange member through which it holds the shares at the Tel Aviv Stock Exchange member's branch or via post office to the shareholder's address in return for a delivery fee only, if so requested. A request in this respect will be provided in advance for a specific securities account. The proxy statement must be provided to the Company's attorneys to said address so that the proxy statement reaches the Company's attorneys' office not fewer than 72 hours before the date of convening the meeting. The last date for producing a position statement(s) to the Company is up to ten days after the record date ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">the last date for delivering position statements</font>"), namely Sunday, July 3, 2011 and the last date for producing the Board's response to the position statements is five days from the last date for delivering position statements, namely Friday, July 8, 2011.</font></font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">One or more shareholders that hold shares at a rate representing 5% or more of the total voting rights in the Company and anyone who holds such rate out of the total voting rights that are not held by the controlling shareholder in the Company, as defined in Section 286 to the Israeli Companies Law, may review the proxy statements as detailed in Regulation 10 to the Israeli Companies Regulations (Proxy Statements and Position Statements), 2005.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The required majority in the annual general meeting and in a postponed annual meeting (if any) for approving the resolutions specified in paragraph 1(a)-1(f) above is a regular majority of the total votes of shareholders attending the annual general meeting that are entitled to vote and have voted therein.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The documents pertaining to this report may be reviewed at the Company's offices at 85 Medinat Hayehudim Street, Herzliya, during regular office hours and by making an appointment at 972-9-9557080.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's representatives for handling this report are Mr. Ronen Kantor, Adv. and/or Mr. Ron Soulema, Adv. of Kantor &amp; Co. Law Offices at 12 Abba Hillel Silver Road, 8<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> Floor, Ramat-Gan, Tel: 972-3-6133371.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yours truly,</font></div>
</td>
</tr><tr>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td nowrap valign="top" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">XTL Biopharmaceuticals Ltd.</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 6 -</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contact:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investor Relations, XTL Biopharmaceuticals Ltd.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel: +972 9 955 7080, Email: ir@xtlbio.com</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cautionary Statement</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Some of the statements included in this Form 6-K may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 7 -</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="46%">

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">XTL BIOPHARMACEUTICALS LTD.</font></font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date: June 6, 2011</font></div>
</td>
<td valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ David Grossman</font></font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David Grossman</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Executive Officer</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 8 -</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`-@"B`P$1``(1`0,1`?_$`,L```("`@(#````````
M```````*"`D!"P8'`@0%`0`"`@,!`0$`````````````"`8'!`4)`0(#$```
M!@(!`@,"!PL'#0$````!`@,$!08'"``1"2$2$S$405&!(A6W"F%QD<$C%G<8
M.'@YT3)"LB276/"AL>%24]/5EM875V<:$0`!`@4#`00%!`P,!P$````!`@,`
M$00%!B$2!S%!(A,(46$R0A2S=!4V<8'14K(C,W.35!8)D:&Q8I+24],D-1<W
M\/%R@J*C9%7_V@`,`P$``A$#$0`_`'^.$$'""(D;U;;U+1C5/,&T-QB'=CC\
M90+5Q&5=BX!FZM-IGY>/K51KI'QD7!(Y*6L<NV26<BFH#9`3J^0_E`II!BN/
M565Y!38_1J"7ZA<MQU"4I!4M1';)*20.TZ1I[_>&+!:7KK4:H:3H/2HD!(T!
ME-1`GV0I/I[]J2V'N&T5(I^SF)\/)8-RA>X&FG<XTC[3#6K&!;3*MX.)G2/Y
MJQ3K:WQ46^?I*2"*S=LX4;@H=$Y#E*B=A,IX`MEOQYROL%34KNE.T7%)=V%#
MNT34`$A);,@=NJAH$GKN%/V'ERLK;PFDN3+(HG7`D%&X*1/H3,D*`[9"?HAX
M_BMS!Z1?$'""#A!!P@@X00<((.$$'""#A!!P@@X00<((.$$'""#A!!P@@X00
M<((7T^T#8VW-C=<FNUFF.PV=L5S>`FKUQF''V+,@62N1-RQ0\537D+F6$B':
M:#BRXX=E%TNJ4GG5A57(G$?=4@Y;/$3^+/9!]!Y724]135D@TMQ`);='1,R0
M=JQI_P!4I#4Q77(C%\:MGTM8ZA]IQ@?C$(40%()GNE,":3U,_9,STA2K3#N&
M9.V)R/,Z?]Q#9',&5M6=O:\WPG8YS(5XD;4YPM?9">BYK$69JJK87#AI%.ZI
MD.,8D?&/_9U8]RH*Y3%2``8?+L#H,<H6\MP6C88OEL67]J$E(?9VJ#S2@)S)
M03+5)ZA)!,4_C^45=XJ%V#**AQVV5B=DU$J+;@(+:TSGT4->R4Y]D6?(?9^:
M3VWWUBWBW1V9J61M>M8'#;*,'CBCU"8K5LS!;JY+LW.-:%./)N3>L(%*TV\K
M%JNW8C('<BIZ7JHI"=4L$?YCN.=L-8?C-"JGO-Q'@K=<6%)90H'Q%I"0"=J)
M]Y7LB<DE4C$I9XVHL36O(KS4AVBI>^E`!!6L>PDG20)Z]=)_9BH&K=Q_NW;@
M[*1]+Q/M?L6RR)G_`"BNTIV-:%D^T5ZEUMY;)==RA#0L4Q>)LJ]2:?'*&,HI
MY2IM(YH=90?FF'EC5^!\9XICZJV[4-(MFDI^\XM!4MU24]IF)K</02$R0!KI
M$)I<MS._WM-);ZI\+J'>Z$J4$IF9RTT"4_8T`F>AB_KODV3>?1?7SMWXKP?M
M-MC9KZC"Y>:9LRS5KGD"0M>3[6U0QV_4FK7)11G+SZ+0EI9^2%:+B!63$01)
MU$AC#3G$M#A^47:\5=_I*!%-XC2F&UA*4-I/B#:@%0Z`)W$=3KU,6/R'5Y'8
MZ2WTUKJ*@U'AK\125*[Z@4:D]="3M$_9^Q.%OE^X-W=FJ"SIUM7O<U:MDE'#
MERYN.6&[9LW1(*BR[A=9(B2""*91,<YA`I2@(B(`'+R3@_%2U!"*2TE9,@!L
M))]`&^*J5E6>)!4JHJP`->^K[L<1:=T?N;/W+=DPWIVV?/7BR;=FS99@NSMV
M[<+&`B+=JV;O5%W*ZQQ`"$(4QC"/0`$>9SG&?'K2%..VN@2VD$DE$@`!,DDJ
MD`!K&(C.<P<4$(K*DK)Z;U_=CF?Z_P#W?O\`%)OK_P!5Y=_X'-?^Q/%'ZI:/
MX4?WD9G[4Y[^L5?]-7]:.(R'=`[GL0]<1LMO%MY$R30X)NXZ4RW>HY^T4$A5
M`3=,GCM!TW.*9P,`'*41*(#[!#F>SQKQV^@.L6R@6T>A2@$'[!"I1B.YQF+*
MRV[65*7!U!6K[L;(7M/WV\91[<>G>0LDVZP7R]V["=9FK3<+7)NIJQ6&7<G>
M>\2<Q*O5%73YZN!0`RAS"8>@<1_-:2FH,NN-%1H2W2-5;B4(2))2D*(``[`(
M:G%:EZLQ^DJ:A14\MA))))),SJ2=3]N+"^1B)#"\?>[SYF[#-SP"TQ)EK(.-
M6T_4\A.)IO2K1*5]&4<QTG6B,'#Y*/71(Z6:$=*%()P$2E.8`]H\=7RGX'AN
M8VF^U&46VDKWZ9ZG#1>0%[`IM\J`G,2)2DG3L&HCGCYV.1\\P;),=I</NU=;
MJ>IIJE3J6'2V'"AUD`J`ZD`J`/9/3UW[TMRX>4ZINW:RCETZK4$Y<N%CBHLN
MX7BVJJRRIQ\3J*J&$QA'Q$1XF=8A+=6ZV@20EQ0`]040(Z!6]:G*!AQ9)6IE
M!)/4DI$R?7')>8T9D1\VNC\GRNM^:(W"QYQ/*[Z@3K:@*5J23AY\EF4;=(XT
M3**NF*3!Z"O\Q4RR8%'^D')7@KMA8S.UNY0EM6.)K6C4A84I'@[N_N2D%1$N
MP`DQ`^4*?**KCV\4^%%U.6+H7!2EM00L/$=S:M1`29]"2)>F(?\`:\J^X=6Q
MYDYMN&YR.ZM+J]QZ]0/D>VM+<^+6RUMHFY+'.F<O+D9L_I8%/,D8Q!%3J;H/
M7KRR^?ZWBROR6A<XG12MV9-%)[P&G&DE[Q%^TE:&YG84Z@'LUTTI_P`KUMYC
MMN+7%GF95>J]&O!8^+?0^KP?"2#L6AQR2=\^Z2-=9:S-H?*)AG(.$$'""#A!
M!P@CTI*-CYB/?1,LQ:2<7)LW,?)1S]ND[8OV#U!1L\9/&JY3HN6CMLJ9-1,Y
M1(<AA*("`B'/MMQ;2PXV2EQ)!!&A!&H(/80=08^5H2X@MK`+:@00=00="".T
M&-7-WG>W+(]NW;RPU2MQCLFOV6AD\A8"F#>J=!E77#TOYP8Y</#&,8TOC>5>
M%:E\QA55C%F3@WSE3>5]>*\Y&:XX%U"PJ]TP#;Z3[VD@Y*6J7!U.HW`CI"DY
M_C*\8O953B5M>FMK4'IU3_V'T^HSUCT]W.[5G/=K5#4C5Z\+OVS#`5?-_P"4
M;`I(>LIFF]P1G==Q_;IA-/R&`U<H/D*N58#&<33MTZ$>GH^4P[C:UXCDEQOM
M*4$5"B&4E,O!:4-RT@ZR)7TE[@2)ZD1\9'G-9?K-1VIS>/!1)9G/Q%2DE1])
M"?3/4J]1AEG[,QVQSXIQ\OO_`)GK@M\BY;@UH?7R(E6Y0=U+$;\"A*9`*BJ4
M5&<QE`Q"ILS_`#5"0*0'*(IR!RA1'.>>)O-R_96UK)MM*L%XCV77AT$^A2UV
M?SYGJD&+9XHQ0VNB^G*Y)%:^G\6"/9;Z[I>E>DC]Z#V&&V.@=>OP_?'B_2$7
M%$8=W?#2_;L0]OZL&?1]O_RFV<WF,)"LEMZ5:I-<P/\`VHC57T3LE8/_`)7?
MDU1JTNVY^W_HR("("&UF`!`0\!`2Y+K0@(#\'3IQ]L_`&!70=AM[W77JVKT_
M\#LA1,04H9=1$'7XQL?:*P#_``CK&W,YSMAT(U9??-_BR[JCX]1R)6/:(C[,
M6T(H>WXBE`.=`.(?]NK7T_)K^6<A.>1B3F5=/^T'X(A_WLR?PLM&?T`5+^N^
MXEW('UWNOSYW\,PSN%_5>B_,#^546;\B$2F%B_M`9!/?=9RA[35#)A0^^:7J
M10^\'4>=`_)3_DF2#M\:E^W^+J-!Z3ZNV.77[P12497BREF2?A*N9]`\5F9^
MU'8%I[DNX>;90N/^WIA=_:J=0(B$@YG)KREKV)Q+RK.):)N3H%EG<=5*Q&J*
MIG]U2>&6?.D@!7R)`8"<AMIX*XTQ&C;NW.=Y%%>*[>XBA;<"5-(*C+>I"7''
M%_?;4I0D]W>2#$RO/F6YASVX*L_ETL;E;8J!"6W:URG*_%6E*00GQ%(9;3.>
MU)*W%CO$)&D<(J_=HW2UNR+"5'>'"QQ@)4Q#NU4J6XH5U0C/7*@XG*RHF[6J
M-O;LC&_*-TRH^<?F@NF80Z[^N\M'&6?6-^[<,7L/5]/IX:WDO,K5*8;62A#K
M"E>ZM6Y(.A2!,C06KS;\R<;9,S9>>K'X5M?`45I8^'?0B>TN-R4IEY"3/<D`
M$C4+!E.\G+FPK&+U)ONR^'9*"MK&,Q'.9,HKYV1RY@IDK.%7DXXL@W;KLGP(
M"JGZ;A$%$5TCE,F82'*(`HV,8<_<N0Z#!;\EZC?>N:*1\2`<;)<V+`"@1,=G
M8=#T,/%FO(+5LXFN')F)K8K&&;2NMIBJ9:=`1O1NVE*@#T(F"#H9$2B-7;%W
M*R;N?C3(=VR=#4Z#D:GD!*IQK:F,99@Q68'K,5-&7>$F)B:74=^]/S%`2*$)
MY``/+UZB,[Y]XKM/$F545BLU34U-+56_X@J>V;@KQ5M[1L2D;9)!],Y]D5MY
M8.:,BYMQ&OR')*>DIZFEN1ITIIPL)*?!;<W*WK629KEU`E$<-U^[BZQCDESK
MYJI2&V6<M-)4*W,3SAI)3L!&6D5?16J=;KD`HE*W*QLU`%-P)%DF[=<HI!ZQ
MRJ`G/N*_+1^T>/C/.1:\VC$_"+J$30AUQH3D\M;@*66E2.R:5+7U``E.MN:O
M-RYC.4'CGB>@%YS-+O@N.%+CC3;W]BRTU)=0ZGHLA00V9COD$)C)-[;=[#&$
M,IDZ^829N*(R1"5DV#K%L,Z3CHLA?>7"DLPJ-C&Y0C5%N4055<`7W</%3H(#
MR;T'''E.R.I18;-?:A%X=(0A1J"G<L]`A3U.EA:B>B0K7W8K.OY;\[>+TAR:
M_6!"[(UWW$?"-*"6P>\5)8>-0V`-9JZ"9)$HL_T"[C>/]V8>2@UXDF/\QUEB
M61L%$5D?I%E*POG0;C:*A)'1;*R$.5VN5-PBH0KEDH<@'\Y#D5/0O,G!V0\0
M7!!J'/CL;J%J2S5)3L[PU\)Y$U>&Z$ZZ$I6)E/0@-)P%YB<=YOMSK*&O@,MI
M4@OTBE;P4'3QF%R25ME6A!&]M6BIB2C9%RDH8J#A!!P@A6W[5#EW7:&T\Q_A
MF\Q#:R[!W?(,?;<'D:.D6\QC^,JRI&]^O<BH":K@*W*PS\83W0WE)(/'A#E'
MJR,9.^/+];KW494Y=:%1;LK#114$SVK4N8;;'85!0W3$]H!F1NUJ#F"NM;5B
M11U("[BXL%OI-`GWE>D!0$NV9$Y=V$'*G+Q5?ME6GYZLL;K`P5D@IF<IDFZ=
MLHVWP\7*M'TI5Y!ZQ42>M&5@8H*-%543%4336$Q1Z@''&KF':FA>IF'%-/N-
M+2E:9%2%%)`4`=)@ZB>D+;;W6&:QMVH3N:2XDD>D`Z_Q1MYM1=@,1;1:W8@S
MC@M5F7&5YID6ZKL.T2:M35'Z/1"*D:,^CV0%;1<I2I)DK&.&Q`!-)1J($ZD\
MHCS5O=IN5BNU1:;NDBXLNJ2YJ3-4_:!.I"O:![09Z=(=^T7&CNUM9KZ`CX9Q
M`D![LM"D^@I.A^Y$C^:N-E$7]W?V+]O/W7\^_53;.;W%_K-;OG]/\JB-7?/\
MDK/FKOR:HU:?;<_;_P!&OWJ\`_656^/MG_U#NGS!WY,PH.(_6VB^>-?*"-N9
MSG9#I1JR^^9_%EW5_2)6/JNH?.@'$/\`MU;/S:_E5PG'(WURKOSH_!3#_O9D
M_A9:,_H`J7]=]Q+N0/KO=?GSOX9AGL+^J]%^8'\JHLWY$(E,+#_:"!$MYUJ.
M'3YE.R:?Q'I_-EZD/XN="/)$I*;5D)5T^)H_P*B.6O[PQ`7DF,)/;15GRC,7
MG:28@@L'ZL83H<(R;M5$Z%7I^Q.$4$T59:V6>,:SECEGIDR@9=TYDGIR@8XB
M8J*9"!\TA0!,.3,DKLLS^[WRO6I:G:YU+8*BH(9;66VD)GT2EM*0`-)S)[Q)
M+_<.8=;\$XRLN.6Y"$):H&EN%*0G>\X@+=6J6I4I:C,F9D`.@$1[[M&):YDO
M2C*TQ*,&RT_BR/;Y*J4JHFE[W%/H)\S)+IMG!B"JFA+5UPZ;JIE$"JB8@B`B
M0HA//+9DU?C7,5J:HEJ32W-PTE0D$[7$.)(3N$Y30X$*293$M#(F*Q\W&'VW
M*>$+M5532%7"UMIJZ=P@;FUH6D.!*NH"VRH*3.2B$S$P)5@Z,Y#E;1VC=U:5
M)K*.&^,X7*C"#.JH<XMX>TTA"R"P3`PB":*$PX>*%*7H7\L/AR_>7K#3VOS6
M8Q=*:0^D7J)Q:0`!XC;RFE+,@-5)0F9[93[86'A'(*V[>3/,;35J*D6QFN::
MF2=K;C"'0@3)DE*E*('0;M(\.UQDE]A[MU;O9/BC^G,4N<L<Q"*_[J<#%\$U
MA5O#Q'T)1RD?I\/EZ<^O,ECS65\_8CC;^M-64K#:])_BS6.%?_@#'Y^53*'L
M+\LN;952S%915=0XT09$._!LI;/VEJ21ZQ'U.P]@^$GYG,NQ]D:EF+-7Y1A0
M*E(R)2NG$<^F8XU@N\XBLN4ZA9>20?,VPK@/J>BHN7KT5-U_+SG996L.6C`:
M`^!9_`-2ZVD@!6U:FF$=V7<;"%$).DY$#01G^07"J.N%YY,N0#]W34"D86L!
M2FYI\5]P*5,[W-R$%0UV[@3J899.4#D.0P`8IRF*8H@`@8#`("`@("`@(#\/
M$0F1J.L=+"`1(R(]?2%'M@*\ST=[M]+G\:H#!5>?NF/+D2O17]C9(5G*S]2L
M7JL-T42^D2)6>C(G11`HII$.F4H`"9>G2+%:MWE_RJUM#D1\>[4--4-AU9W'
MQ*)/C4[NX][?X02VHG4ZDDS,^2&8T;'!?G%HJK'9L6>MK*9TLH[J0U7GPJAH
M`:>'O\0I$I"0``($-P^7[O\`1\O^OG-V.M\D^C_EZ(\N$>QU3G+-6.]=,0Y$
MSCEB>0K6.\7U:3MMKEU^AC(QT:B)RM&2`F*9[+2CHR;5DV(/J.G:R:1`$YRA
MS,MMNKKS<6;3;&R[7ON!"$^L]2=#(`343T`!)T!C#KZZGMM$Y7U:MM.T@J)^
MQV#UDZ#UQJIMQ]HLU]S;<NP95DH:6F;EEJWPM`PUB^,.9^K6JRXE0@\:XU@4
M2!Z2CLJC\IG:Q"E*[E';ER;IZ@].@V-V&S\=XFFF*T"EIFE.OO$>TN0+KGI(
MD`$@:E(`$)[>[I<,RR'XA`FMUS8VGL"?<3(>@?PG7J3%U7=>[$J>F6@FNF>\
M8H*6"^8@KK2O;G/6`KN49V3N\F,FADID03K$;PM%M,I^;@^GY"FB5&2YR@**
MZ@U5QMRZ[DF6UEINQ2W25:RNC!E^+VC5F?:7$C>.SQ-VO>`BP,VXZ1:,<IJZ
MWI*JEA,GY3,RK7</4#W?Z/KCC_V;;N8?JRY[6T[RU8/=,&;(6!L-$D)1WZ<9
MCS.SI-O'18E.L;TF,+E)LW1C'0^!2RJ3!0?*4[@X^\ZX(N[T'[76MH*KJ1`#
M^T'<M@$]Z0ZEJ94I78@DGH(_/BC+#;ZP8_7K_P`*^26Y^ZX9"4^P+`E+I.73
M6-A(`@/L'KT'I\O%`!!$QJ(9*(P;N_L7[>?NOY]^JFV<WV+_`%FMWS^G^51&
MKOG^25GS5WY-4:M/MN?M_P"C7[U>`?K*K?'VS_ZAW3Y@[\F84'$?K;1?/&OE
M!&W,YSLATHU9??,_BR[J_I$K'U74/G0#B'_;JV?FU_*KA..1OKE7?G1^"F'?
M.T9MGJM2.VCI=5+GLQK[4;3!8+JT?.5JSYFQS`3\,_1,\%9C*PTK8VDC'/$O
M,'F263(<O7Q#BBYWC]^J,SNCS%#5K956ND*2RXI)&X]"$D'[1AC<0N]I8QJB
M0]54R%A@3"G4`C4]A5%C/Z[NE_\`B[U@_O\`<4_]V<BG[,Y'_P#GUWZ!W^K$
ME^GK'^NTGZ9O^M"[G?#S+B#,=OP"YQ%E7&V56T+4LB-9IQCF]5B[MX=S(2=9
M.Q0E%ZS*2:4<N]3;J&1*L)#*`F82@(%'H^ODSME?16C(6+@R\PMQ^E`#B%(*
MAX;\Y;@.P]1',#]X'74=7DF,.T;S3J&Z2J)*%)6`?%9E/:3Z)R[897UOO4%D
MK`>';Q6GC=_#6'&].>M7#8WF3*J6#9MG[,W^PXC9)!9NL0>@IJI&*/B'$.RR
MUU5CRFY6:N0INKI:UUM25:*$EF1(_G`@@]H,Q'2;`+Y29+A-IOM`M+E+56]A
MP*3TU;3N'V4J"DD=A$C$5>ZMD6#Q]HUFX)5RB1[=X1ICFOLU%"%5D)BV231J
M=)L4QBF4491"+IV8"]1*FW,(^`<LOR[6*IO_`#'9D4PFW1OFJ=(]QMA)7,RZ
M`JVH'I*@.V*@\U^246.<$7Q=4H>+6LII&@9=YQY:00`>I2@+7I,C:3V&*I]%
MJ'(5OM%;K71\0R2&28G+#R'(=$R9U8NJ49I6CNRG,`>JBM+MW:91#P`4AXQ'
M+U^I[IYK,8MM.0KX!ZA;7+L6X\IV1]!"5"8.NNL*GP?CE3:?)?F%WJ`0+DU7
M.(GVH;82T#ZP5)7J/1'Q.VSCR0ROVT-[\>P[<[R:L<K8DH1FD!C*NYF.QI7I
MB*:HE)T,99P_CDR$#X3B`#X<S_,%?6,9\QF&WVJ.VDIJ=A3A]#9JW4+.O8$J
M)C`\LN/U65>5?.[!0IW5U14U'AIU.YQ%&PXA(`U)*D``#MCLWL%Y=@TXG..#
M'KQNTLBTY"Y/@(]<WI.I**5BD*Q900(<0.LM"NXY@94H`(D*[`1\`$0COG1Q
MVJ3>K1ES2=]N=IUTBUIU2AQ"UO-@JZ$.(6LH(Z[3UD8EW[O[+:$6:]X&Z=EU
M;JTUB$J([[:T)9<*1UFA3:"H2]^&.A'H`C\0"/X.(^HA(*CH`(Z-0I3N7-M]
MI^[?1*/CUP27)6KGB3&2TDR'WIF5Q19M6TWMX11$#]6M>5=/DEC!U`#LSCUZ
M<Z-<:4[W'_E7N%YO0#+E92UE0A!,E*34I^&IQK+O.#8L`>ZJ.2G+54QROYQ[
M;9\>4'Z>BJZ&E6XG5'^%7XU204S[K94XDJ]*8;6Z_P"CKSG+,?Q1UKC//8(6
MI[]VJ_<XWM;T'7?5'%L$ZUO@1:7K(MBE,M4.H/<DY`356)7X!:#F)IM)EJU$
M0(+H`6(0CR4<D4\H@S1.:Z>(K_@^)5+]\R)YWZ7(\-I*6EK"$'52Y@2W*/=$
MM0F8G(RBK^1K-E&14Z+59VT_1_M.$K0"I78F2E)(">O:"3/J!$2NQOV(\\:N
M[-2VS>[=)JD%*8QA0:X&JD7;ZS?"KW6QHO&,W?Y):`<R+*//4H#SMHY-0P+"
M[D3."@46R9AD'+?+-JR>SM8_C*G32N+W/K4E2)A'L-@&1U/>)&F@$:3CSCRL
ML5P5<[X@?$(T:2"E4B?:6=I/0:)F>I)EI.&V\@T*HY2HMPQM?8-E9:3?*S-U
M"V5^03]5E,5ZPQSB+EH]P7V@1RR<G+Y@Z&((@8H@8`$%\I:E^@J6JVD4453*
MTK0H=4J29I(^P1%R55,S64SE)4)"F'4%*@>U*A(B->'F7[,_W)*IE[(,1@VC
MU*_XGA[E*CBR_.\O4.ISTQ3RO1>5>1DHB5F64M#6)BR.DDYZE#H\0.=(PD$A
MA<ZV\[8/4VMGZ74ZW7J9`>;#2U)WE,G`"`04*,])]#(^B%HKN*,G9N2W+6E*
MJ8.3;5O;293T)!6"#+KH.T=(>3[>J^W*>JN-J]O#36%4V)I+$:7;9.+N%<NC
M'(3*`20:P61!D:T^?-FDK8HOT_I)NJ8J@22*ZI2@DJGQ2\H38Q?:A>-K*[,M
MPK;F@H*0HS*-IU[I)`/HEJ88/'?I46EI%Z0$7%`VJDI*@K;HE4TDC42GZP3(
M3E'<NT%(L>3-:-B,;TYFC(6[(.#,M4BK,'#QO'MWMCM=!L$#!M%W[LZ;5BBY
MDWZ1#K*F*FD41,80`!'F'8ZMB@O=%6U)(IF:ME:R`20E+B2HR&ID`3I&;=&'
M:JV5-*R`7G&'$I!,M5((&O9J81$TO[`'=$PSMKJSEJ_87H\92<8Y\Q'>[F_:
M9JQK*.HZLU2[0LS.O&\<QG%GDBNUCF:ARHHE.HJ8OE*`B(<:S+N8\&NV+5UI
MH7WE5;](XVF;+@!4I!`U(TF87NP\:9/;;_37"H:3\.U4H63O;Z)4"=`LGIZN
ML;"_B?PR4(?]TKL9]R+:#N`[-9\PWB.FS^,LDW&#EZA,2.7<?5]\_8,J)4X-
MPJXAI>9;24><DE%+D`BI"F$"@8/`P#QL>/.7<*Q_#J&SW-YY%<PA06`RXH`E
MQ:A(@2.A'2%VS'C?);QD=3<J)M*J9U<TG>V-)`="L'L]$5^F^S8]V<PB8V!<
M=F,(]1,;.6*1$1^,1&?$1Y-/]=>/.OQ%1^A=^Y$='%>:I$DH`'YQO^\C'_YK
M^[-_Z$QS_?CBC_GW#_77CS]8J/T+OW(]_P!+,V^\'Z5O^\B:.I?87[DV*$+@
MWO6&*5'I3<I7%VY6&8<;OA6:L4WZ;T3"RFC^B<A7(`'4.H]?#KTY-L5\R?%]
MCM]<EZLJ45KR1X7^&>4-Z4N!&Z0T!6I,_4#.*`YL\M'*>>7"SJM-(R]14WBA
M\JJ&4*2EQ;9[NY<R=B52E.1EI.+IU==>Z#V_I6PUS4-\?,V!9>4<R\!7WK.N
MV-[!+R)BJ*IR-4F'L9*Q<LD"8%7<1"YF+TP`L<A%#&*6!#-_+[S33LW/D]#E
MFSAMH)?=:\1"*C:``H.(0XA0/NAU"5HU2%E,H_9/'/FF\OE546?B)Q%]X]==
M4MAIP,NK8W&9!:6MM:%=BBRI3:_:V@DRX(KI9W*>X)D"K3>W\DKBO&L$Y,)6
MLC]`1ZD,T4]`DE^9>-X!T\$;#*)$`GOTJ<GD`.HG.0H)&W+?+'`_"EEJJ?B=
MA=QR:H3^5(=()'L^/4.ALEM![P;93(J'61,:%W@SS(>87(J2X<VO"U8I3J_)
M`M)4E)]H,4K2G`'%]/%>(4$SF3*1O(S'KV@STJR'K7A"O-D0'"E@QQC^!5>M
MF*2KIU!N&#`KZ4>G0;%<OWBHJN72QB@HLH=0X]3#Q2L2S!3/*=OSS+'EN%-W
M;JJIT)*ED>)O6I*$S)E[J1H!H-(>//<`\3A:Y\;X/3(2565RCI&2H(3/P]B$
MJ6H@`DZJ6HZDDGK$5^TKJMFO53$V3:CFZMQU<FK+DM&S0[>.L4/8TW$22IP\
M49=1Q"NG:#=0KYD<OIG,!^@=>G00ZV+YE^1L4Y.S&@NN)NNOVVGM?@K4XTXR
M?$\=Q<@EP!1&T@SZ=D59Y1^)\SXCPFXV3-F&F+A474U"`AUMT%LL-MSW-J4`
M=R2)$SEK*41,V[[66:Z=FUQM'H384Z[:G$P\M+Z@,Y9I6)B$L4CZYII[1Y22
M`*Z]A9TRZAG,0_%%(!6.0@JHG!%.RN-O,3B%RQ!/&_-E&JKM*&TMHJ=BG$EM
M!_%!Y*5!Q+K>@0^T=X2!,3!*JEY9\K6<6+.E<J<`5(IKJIQ3JZ1*TLK0XL'Q
M2PI<FEM.^\PX0`20G<#(=8S-[[[.5(5?&BN/I6G%DFYHF1M\;7\?T>460%(4
M'*I[<M.K-(SUR=1,O&IH*]1_)"`].;JBM'DZQRO%_57N5C39"T4ZU53Z`>H2
M6@T@N2^]>)2??!B.5E\\^6642L:-M%"'!X;E0A%)3KD="0^IXA.GOLI!U,I1
M/#MN]LIIJ2J_RME>6BKGG><8N8M!>+,Z=0%#A7_D/),H=Z_10=2T_,'+Y7LB
M9-,!2#T4B^0RIUJ@YVY]?Y76BPV-A=%@],L*2TM*4NON(T0XZ$DI2A`'XIM)
M(3.9),MM\^6WRST_#P=RC)GFZW/ZI!2I:"HM4[:Y*6AM2@"M:U?E'2!.6U.D
MRJW;H'Q?!T^3XN+E(0VDA&>>Q[&/D$?P?C'A!&>$$'""#A!!P@@^00_!^(1X
M00<((.$$'""#Y!'\'XQ#A!&.OW!_S?R\((SP@C'R#]_P_EZ\((S\G3_+[G""
1#A!!P@@X00<((.$$'""/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`*@`C`P$1``(1`0,1`?_$`+````,``@,`````````
M``````D*"P<(``4&`0`#``,!`0`````````````&!P@#!`4`"1````8!`04%
M`0D1`````````0(#!`4&!P@`$A05"1$3%C<8"C1$)34V9A<X.2$B,E(S8X,D
M1556AD=GQ[@9$0`"``,&`@<%!`<)```````!`A$#!``A,1(%!B(305$R,Q05
M!V%28C060H(C-H%R4V.SQ#5QD<)#@T1T10C_V@`,`P$``A$#$0`_`#Q=2[KM
M6#IGZ@4\+9#T3V>\5NQUMC;\9Y6B,SQ<%`WZ#4*FTFR(Q;K&\HI$3E6GN\:/
MF1W2RA""W<`/=.DNUR;&])I.^='\SHM425/1RDV49)9I;8K?S1%66#*T`,5Q
M4V6F[/4*9M/4/!U5"7DL`R3!-@'$+[N4T"#$$1)NC@PB*G7'[0I8-5O38R#*
MZ7XBU:9LRESO2<5Y6C&]O;V&XUW"=RJUKF65YI]OC(2OJ,&EOL]<+77;E%!%
MS&G4[H%`.];*"P-J>C<G;^^),O7VEUVF>$>;*)3*C3T=%,MT+-$HK<Q020T(
MPX&%@[<'J9-UC:LR;HRM3UO/$N8`Q9EE%';.K!5A%E"M<,HA?QBP'.E-KNS3
MI$UIX9M<9E:Q1>+KEDBN0>H&!GIZ0?4VQ8SF)$C:[V&RQSU=PW4E:C!+.)=K
M(%+QB"[,-TYB'434;GJ#M'2]Q[7J:=Z=&KY4AFIV50'6:HBBJ1?!V@A7`@]<
M"%ILK<NH:+KLF<LUA1S)JB<"3E*%@'9AUJI+`X@C^]D2<]KFQFC8YB,JFB#(
M%HA$IV0CZQ+K9FA8>5LD6205:PDD>MDQM++1<A--025X$'#DZ*BO==XH8-X4
MC*_\Z5YD+,J-4DRYN0%AR2P4PBPS<T1`,1F@(XP%FR_K31FH,FGH6=<T%)FP
M)'02.48>V\@=9%]CS^K_`%=\HXG_`)YW'G/HQ]3G*OIEA>%^EWQORCTA\T\!
M>:_@/X:XWN.!XSX/W/?>RD^F]N<S+YS*Y7F?A8\EH\G)'QD.9W/,X(1S0XX_
M9LQ?.]9R1\MF<SP//AS!V\\/#QR=[DX\(1X?BMY;J]].J`ZC^DBRXU9H1[+-
ME"%Y?=/]K>=TARN^LF1B+5B0?'`#(5?(,<F,8_`3=VB<[=V)3G:)AML>G&])
MVR=Q2ZYBQTN="74(.F63VP/>EGB7I(S+$!C;#O7;$K=&BO2`#QTN+2CAQ>Z3
M[KX'H!RL0<H%IGV&<AS6EK.HN<AXQ96Z-K<S,8ZSU@3(+%1".N]13E2Q>1,8
M6AHIN.8F71<1PG9/$Q(ZAYMDU>H&*LV(;:Y=4HI6X=(A13S+F.HF2)\LWH\(
MRYBG!A?Q#!T+(>%C:3M-JYFA:KEJI8>6K9)LMP0&4'B4]*F['M(P#`9E$"3]
M4JT=+RAQ&.L9=,C'#8"Y.IU<RGF3+T[;KG=['6XNRL4Y2MX!KP6ZP32-/DH[
MO>*MI4"\:"I&L>HX$I7B1@?8%/OVLFSJ[?<\_@3&E29*HB*Q4P:>V15S@X2H
M\,,SA;U-BS>-3M"EDRZ3:<H1G(LR9,+,Q6(B)0#,<I6/'TQ(7-PL#NI[-ETQ
M@U(YM/K4S!7N*PAIXL:2.,HR4:[\?D3.K`B#YH_!)4HIO8#%"2Z+Y0?P%)I5
MF0!,#9RF`OZW[[\ETOZ7TUX:I6)^*0;Y<@Q!'L:;>HZD#&Z*FW=]*-H>95OG
M]<L:*G89`1<\P0(QZ$N8^W((D9A:@GM'=J7MS;UO61&]J5T&T'%.2L>ZXL?R
M5;KS[/LZI0<KX_XMHQEK!?8&!4D(W*-;B"B5602?5^/!E8E$R`5%VFQ7.)E7
MJIAK/T"W;6:A13MJUBNZ4B<R5,@2%ELT#*9NB#&,L=*YP+D%IU]8MN4U+/E[
M@IRJO/;*Z1`)8".<#I!%S'`-`WF8399+3-A!YJ5U#86T_1]JKU%>9CR15\?H
MV^T.DF<)7AL4DDS5DG)E3$*Z=II&,#1J`@H^>F2;D'?5+L]M>U5=#T6JUAI;
MS5II#S,B"+-E$8#J'6<%$6-PLHM$TXZOJLC3LZISIBKF8P`B0.L1QP!B<!?:
MMQIOT^8TTJX-QGI\Q!#%@\?8MJ[&M0;<VX9Z_.@!EY2?F7"9$P?6"RRZZ\A(
M.!*`KO'*A^P-[L#YUZWK%=N#59^L:DV>LJ)A9NH=2KU*H@JCH4`6MC2]-I=(
MT^5IM$N6GE(%'6>DL?:QBQ/22;9NVY5M^W0VJT5VCUFQ7.WS4=7*I4H.5LMF
ML$NY39Q4'`0;%>3EY>2=JB";9C'1[91950P]A2$$1VS4]/.JYZ4M,K/43'"J
MH$2S,8``=)),!;%.G2J>2]1/8))12S,;@%`B23U`7VEC=7'J*6#J/ZM+-E-!
M>28X5HQ7M$T_5-X"J(Q=!:/1.M:9"/[1*A:LB/D@DGWW!511X9F)C%:$$;[]
M.=ER=D[=2A;*=3FPF5#CIF$=D'I26.%>OB:`+&T?;YW1.W5K;3DB**6<DI3=
M!>L_$QO;JCEB0JFVI6H72]J!T@VNA5[.='G,8VN[XZI.9J25PL9!Z>L6MN$C
M"OT'C4Q3QMB@WS<[=^UWBNXN1;F24`IR@(D>C:_HVY:>=-TJ:D^GE3GDOU9D
M,&$#BI$"IP92"+K<+4]&U3;\^4*Y&E37EK,7]5A$?V=((,""""!`VHJ="_J9
MM^H5I6:1&0)E!;4W@5M#TS,S591,CZX,3H*HU#+;5N&Z*C>Z,F"A)'<#=0FF
MKH-TB2C?>B[U7V*VS=P&91K#0JLEY)Z$/VY)_4)BO6A6\D-:I?3W=B[FT<+/
M:.J4X"S(XL/LS/O0@V'$"8`,MC<;*RQ]9,_VG7J=C%1J73BPM8@"2FVL39]4
MDW$N1!6/@ENXEJ=AP5T3!W;BPE!&8FTP[!!@#)N(B1VY3"F?0G8?-F?6NJ)^
M&I*TJD8M>'G?=O1/BSG%5-D5ZM[OY$OZ9H'_`!6@TX@W@7%9=WZ&;#[`O&86
M&=[.UTQO6+J+]2N6J]QNG'318(V109234JL3D[-;8K>7J]1,DX**$A`TI,Z$
MU,$[#D.H+%JH4R;E4"G7K1OOZ;T7R/3GAK5<A$0;Y4G!G]C/>B??80*BPEZ6
M;1\YU+S>M6.FTS`@'!YF(7V@=IAU04@A[-D=;GIJ,NHGI/DD*9%M!U)833EK
MU@N4,!$G,ZYX1,]IQ6[=F$I2QF0X]BFF@)Q!-O+MF2QC%3(J!IY]+-\/LO<*
MM4L?)*J"3QT+?P30.N628]:%AC"#HW_M1-SZ,RRE'F<@%I1A>?>E_?@(7CB"
MQ,(QGS]/W6GDWISZM*3GNLLY<25B4=4_,..%Q5C%[ICQZ_2:7FC2K1T4@-)Q
MDHR!RQ%<G:RF6*!SAV$.4UC;QVO0;UV[-TF>5BZAY,S'),`BC@C$7P:':1F`
MQC:9=KZ]5[4UQ*Q08*V68F&9#VE,80CB"<"%8@Y86I7?]0]%'+N;_3#'<J]'
M7KNYEPCC@?3KXH\$<_XK\AXC\9?!7)M[F',?U?N^]^\VASZ#W1GY?ACS/,O`
M0B(^(R9\L/=R<>?LY>*,+[5C]5Z)DYG-X/!>*C`PY6;)C[^?AR=K-="-IL6N
M/ZYNJGW%Y^9/\\/-[Y52'F%\XOQ_S6YM;^U/RS0?\25W'<]@=W\-I4W'_7*K
MM_,3.][SO&[7MZ_;&S_WL^_V56G3RE]TY(\HO<'F+9?EK_<;]Z?HMH^]8?S_
M`%OS&$KOL>[7L?N_=_3:E?3G\I4W<XOW?ZY[7Q?X<MC1;+&QS:6#U8?M*-:G
MU=//FV_(WXK]Z?&7SU_B/YP<9M?OIW^1],^<^43MX_H^#]G^[RVD'>WYIK?E
M^_?L8=HX_'^T^/-;&7]$/VQ]3S^0OM#/]?\`_)6V[_VGV/ZG_J?T_P#C_P`M
1;6_V/^9\C]SYO^'_`#%O_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
